Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 [ANCILLARY OF 700049031]

Trial Profile

Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 [ANCILLARY OF 700049031]

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Feb 2016

At a glance

  • Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
  • Indications Bacterial infections; Viral infections
  • Focus Therapeutic Use
  • Acronyms VITAL-Infection
  • Most Recent Events

    • 08 Apr 2014 Planned End Date changed from 1 Jun 2016 to 1 Oct 2017 as reported by Clinicaltrials.gov record.
    • 08 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by Clinicaltrials.gov record.
    • 17 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top